MedPath
HSA Approval

ETOMIDATE-LIPURO INJECTION 20 mg/10 ml

SIN08849P

ETOMIDATE-LIPURO INJECTION 20 mg/10 ml

ETOMIDATE-LIPURO INJECTION 20 mg/10 ml

August 14, 1996

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD
Licence HolderB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

N01AX07

etomidate

Manufacturer Information

B. Braun Singapore Pte Ltd.

B BRAUN MELSUNGEN AG

Active Ingredients

ETOMIDATE

20 mg/10 ml

Etomidate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ETOMIDATE-LIPURO INJECTION 20 mg/10 ml - HSA Approval | MedPath